← All companies

PRE

Prenetics Global Limited

PRE Nasdaq Pharmaceutical Preparations EDGAR ↗

$18.57

+0.05 +0.27%

Key statistics

from XBRL data in SEC filings

Market cap

$313M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$7.18 – $23.63

Recent SEC filings

40 most recent

Annual, quarterly & current reports

20-F/A Jul 30, 2026 6-K Jul 14, 2026 20-F/A Jul 2, 2026 6-K Jun 10, 2026 6-K Jun 4, 2026 6-K May 20, 2026 6-K May 14, 2026 6-K May 14, 2026 6-K May 7, 2026 6-K May 4, 2026 20-F Apr 30, 2026 6-K Apr 2, 2026 6-K Mar 6, 2026 6-K Mar 3, 2026 6-K Feb 18, 2026 6-K Feb 17, 2026 6-K Feb 17, 2026 6-K Jan 6, 2026 6-K Jan 5, 2026 6-K Dec 30, 2025 6-K Dec 23, 2025 6-K Dec 11, 2025 6-K Nov 24, 2025 6-K Nov 20, 2025 6-K Nov 19, 2025 6-K Nov 17, 2025 6-K Nov 13, 2025 6-K Nov 10, 2025 6-K Oct 28, 2025 6-K Oct 27, 2025 6-K Oct 27, 2025 6-K Oct 27, 2025 6-K/A Oct 21, 2025 6-K Sep 12, 2025 6-K Aug 22, 2025 6-K/A Aug 22, 2025 6-K/A Aug 7, 2025 6-K Aug 1, 2025 20-F/A Jul 18, 2025 6-K Jul 18, 2025